首页|化痰祛瘀汤辅助治疗稳定型心绞痛的临床效果

化痰祛瘀汤辅助治疗稳定型心绞痛的临床效果

Clinical Effect of Huatan Quyu Decoction as an Adjuvant Therapy for Sta-ble Angina Pectoris

扫码查看
目的 探究化痰祛瘀汤辅助西药治疗稳定型心绞痛(SAP)的临床效果及对磷脂酰肌醇3-激酶(PI3K)/丝氨酸苏氨酸蛋白激酶(Akt)信号转导通路的影响.方法 选取 2021 年 7 月至 2023 年 7 月收治的SAP(痰瘀互结证)患者100 例,随机数字表法平均分为对照组和研究组.对照组予常规西药治疗,研究组予化痰祛瘀汤辅助常规西药治疗.比较 2 组治疗效果,治疗前后中医证候积分、血脂水平、PI3K/Akt信号转导通路因子、西雅图心绞痛量表(SAQ)评分,以及治疗过程中不良反应发生情况.结果 研究组心绞痛疗效、中医疗效的总有效率均高于对照组(P<0.05).研究组治疗后胸闷气短、胸痛、心悸、咳痰量、舌质紫暗、脉象积分低于对照组(P<0.05);研究组治疗后外周血低密度脂蛋白胆固醇、三酰甘油、总胆固醇水平低于对照组,高密度脂蛋白胆固醇水平高于对照组(P<0.05);研究组治疗后血清PI3K、Akt水平低于对照组,磷酸化Akt水平高于对照组(P<0.05);研究组治疗后SAQ评分高于对照组(P<0.05);治疗期间,研究组不良反应发生率 8.00%(4/50)与对照组的 12.00%(6/50)比较差异无统计学意义(P>0.05).结论 化痰祛瘀汤可通过抑制 PI3K/Akt信号转导通路促进 SAP患者病情改善,显著提高治疗效果.
Objective To explore the clinical effect of Huatan Quyu decoction assisting Western medicine in the treatment of stable angina pectoris(SAP)and its impact on the signal transduction pathway of phosphatidylinositol 3-kinase(PI3K)/serine-threonine kinase(Akt).Methods A total of 100 patients with SAP(phlegm and blood stasis syndrome)treated from July 2021 to July 2023 were selected and divided into control group(n=50)and research group(n=50)by random number table method.The control group was treated with conventional Western medicine,and the research group was treated with Huatan Quyu decoction assisting conventional Western medicine.The therapeutic effect,traditional Chinese medi-cine(TCM)syndrome score,lipid level,PI3K/Akt signal transduction pathway factor,Seattle Angina Questionnaire(SAQ)score before and after treatment,and the occurrence of adverse reactions during treatment were compared between the two groups.Results The therapeutic effect of angina pectoris and the total effective rate of TCM in the research group were higher than those in the control group(P<0.05).After treatment,the research group was lower than the control group(P<0.05)with respect to chest tightness,shortness of breath,chest pain,palpitation,sputum output,tongue purpleness and pulse score(P<0.05).After treatment,the levels of low-density lipoprotein cholesterol(LDL-C),triglyceride and total cholesterol in peripheral blood of the research group were lower than those of the control group,while the levels of high-density lipoprotein cholesterol(HDL-C)was higher than that of the control group(P<0.05).After treatment,the levels of PI3K and Akt in the research group were lower than those in the control group,while the levels of phosphorylated Akt were higher than those in the control group(P<0.05).The SAQ score of the research group was higher than that of the control group(P<0.05).During the treatment period,there was no significant difference in the incidence of adverse reactions between the research group[8.00%(4/50)]and the control group[12.00%(6/50)](P>0.05).Conclusion Huatan Quyu decoction can improve the condition of SAP patients by inhibiting PI3K/Akt signal transduction pathway,and can significantly improve the therapeu-tic effect.

Coronary heart diseaseStable angina pectorisPhlegm and blood stasis syndromeHuatan Quyu decoc-tionPhosphatidylinositol 3-kinaseSerine-threonine kinaseSeattle angina questionnaireAdverse reaction

刘晓雨、杜鸿瑶、韩佳、潘晔

展开 >

050090 石家庄,河北以岭医院心内科

063000 河北唐山,唐山市中医医院心内科

冠心病 稳定型心绞痛 痰瘀互结证 化痰祛瘀汤 磷脂酰肌醇3-激酶 丝氨酸苏氨酸蛋白激酶 西雅图心绞痛量表 不良反应

2025

临床误诊误治
解放军白求恩国际和平医院

临床误诊误治

影响因子:0.914
ISSN:1002-3429
年,卷(期):2025.38(1)